Relation of adipose tissue and skeletal muscle FKBP5 expression with insulin sensitivity and the regulation of FKBP5 by insulin and free fatty acids

Purpose Recent studies suggest that FK506 binding protein 51 (FKBP51), a negative regulator of glucocorticoid response, encoded by FKBP5 , may influence insulin action. The aim of the present study was to assess the relationship between subcutaneous adipose tissue (AT) and skeletal muscle FKBP5 expr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2022-06, Vol.76 (3), p.536-542
Hauptverfasser: Strączkowski, Marek, Stefanowicz, Magdalena, Matulewicz, Natalia, Nikołajuk, Agnieszka, Karczewska-Kupczewska, Monika
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Recent studies suggest that FK506 binding protein 51 (FKBP51), a negative regulator of glucocorticoid response, encoded by FKBP5 , may influence insulin action. The aim of the present study was to assess the relationship between subcutaneous adipose tissue (AT) and skeletal muscle FKBP5 expression in relation to insulin sensitivity in healthy individuals and to study its regulation by insulin and circulating free fatty acid (FFA) elevation. Methods The study group comprised 96 male subjects, 49 normal-weight and 47 overweight/obese. Hyperinsulinemic clamp, subcutaneous AT and skeletal muscle biopsies were performed. In a subgroup of 20 subjects, two 6 h clamps were performed, with and without Intralipid/heparin infusion, and tissue biopsies were obtained before and after each clamp. Results AT FKBP5 expression was lower in overweight/obese individuals in comparison with normal-weight individuals ( p  = 0.004). Muscle FKBP5 expression did not differ between the groups, however, it was inversely related to insulin sensitivity ( r  = −0.32, p  = 0.002). FKBP5 expression decreased in AT ( p  = 0.003) and increased in muscle ( p  
ISSN:1559-0100
1355-008X
1559-0100
DOI:10.1007/s12020-022-03018-7